Nihon Trim Co., Ltd. (6788.T)
Osaka, JP
Established in Osaka, Japan, in 1982, Nihon Trim Co., Ltd. is a global enterprise that specializes in the development and marketing of electrolyzed hydrogen water systems. The company's diverse product line includes cartridges and devices tailored for use in agriculture, animal husbandry, and residential settings. Moreover, it supplies medical-grade electrolyzed water hemodialysis systems. Nihon Trim also engages in the production and sale of bottled water, alongside extensive research and development initiatives focused on electrolyzed hydrogen water technology.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.35% | -1.64% | -3.23% | -16.17% | -15.75% | -16.67% | +2.07% | +41.03% | +12.45% | -42.23% | +47.89% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Pollution & Treatment Controls: +8.0%+7.6% Q1'26: +5.8% (vs Q1'25)
-
EPS growth Industrial - Pollution & Treatment Controls: +15.8%-7.8% Q1'26: +28.1% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Pollution & Treatment Controls: +35.7%+9.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Industrial - Pollution & Treatment Controls: +10.2%+12.1% ★ Q1'26: +11.3% (vs Q1'25)
-
ROIC Industrial - Pollution & Treatment Controls: +6.6%+17.1% ★ Q1'26: +17.3% (vs Q1'25)
-
Share dilution Industrial - Pollution & Treatment Controls: 0.0%-1.7% ★ Q1'26: -3.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Pollution & Treatment Controls: -0.39×0.31× ★ Q1'26: 0.33× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
12.83B
est: 13.05B (-1.7%)
|
15.28B
est: 14.95B (+2.2%)
|
15.26B
est: 15.35B (-0.6%)
|
14.02B
est: 14.20B (-1.2%)
|
15.21B
est: 15.40B (-1.3%)
|
16.12B
est: 16.50B (-2.3%)
|
14.92B
est: 15.00B (-0.5%)
|
16.28B
est: 16.80B (-3.1%)
|
17.95B
est: 18.10B (-0.8%)
|
20.41B
est: 20.50B (-0.4%)
|
22.46B
est: 22.40B (+0.3%)
|
24.30B
24.30B – 24.30B
+8.5% YoY
|
27.00B
27.00B – 27.00B
+11.1% YoY
|
30.30B
30.30B – 30.30B
+12.2% YoY
|
36.70B
36.70B – 36.70B
+21.1% YoY
|
| EBITDA |
2.54B
est: 2.23B (+13.9%)
|
3.34B
est: 2.56B (+30.9%)
|
3.14B
est: 2.62B (+19.8%)
|
1.90B
est: 2.43B (-21.8%)
|
2.46B
est: 2.63B (-6.7%)
|
2.54B
est: 2.82B (-9.9%)
|
2.40B
est: 2.56B (-6.3%)
|
2.45B
est: 2.87B (-14.7%)
|
2.79B
est: 3.09B (-9.8%)
|
3.56B
est: 3.32B (+7.2%)
|
3.78B
est: 3.63B (+4.2%)
|
3.93B
3.93B – 3.93B
+8.5% YoY
|
4.37B
4.37B – 4.37B
+11.1% YoY
|
4.90B
4.90B – 4.90B
+12.2% YoY
|
5.94B
5.94B – 5.94B
+21.1% YoY
|
| EBIT |
2.24B
est: 1.94B (+15.4%)
|
3.11B
est: 2.22B (+40.1%)
|
2.92B
est: 2.28B (+28.0%)
|
1.61B
est: 2.11B (-23.9%)
|
2.25B
est: 2.29B (-1.7%)
|
2.30B
est: 2.45B (-6.1%)
|
2.18B
est: 2.23B (-2.2%)
|
2.00B
est: 2.50B (-20.0%)
|
2.38B
est: 2.69B (-11.6%)
|
3.08B
est: 2.86B (+7.7%)
|
3.27B
est: 3.13B (+4.6%)
|
3.39B
3.39B – 3.39B
+8.5% YoY
|
3.77B
3.77B – 3.77B
+11.1% YoY
|
4.23B
4.23B – 4.23B
+12.2% YoY
|
5.12B
5.12B – 5.12B
+21.1% YoY
|
| Net Income |
1.31B
est: 1.17B (+11.7%)
|
2.10B
est: 1.72B (+22.7%)
|
1.97B
est: 1.82B (+8.1%)
|
1.18B
est: 1.41B (-16.5%)
|
1.25B
est: 1.39B (-9.9%)
|
218.46M
est: 1.46B (-85.0%)
|
1.52B
est: 1.62B (-5.8%)
|
1.94B
est: 1.89B (+2.7%)
|
1.65B
est: 1.45B (+13.5%)
|
2.15B
est: 2.20B (-2.3%)
|
2.24B
est: 2.40B (-6.6%)
|
2.06B
2.06B – 2.06B
-14.1% YoY
|
2.22B
2.22B – 2.22B
+7.5% YoY
|
2.48B
2.48B – 2.48B
+11.6% YoY
|
4.50B
4.50B – 4.50B
+81.8% YoY
|
| SGA |
7.05B
est: 7.21B (-2.2%)
|
8.03B
est: 8.26B (-2.7%)
|
8.19B
est: 8.48B (-3.5%)
|
7.94B
est: 7.84B (+1.2%)
|
8.36B
est: 8.51B (-1.7%)
|
8.79B
est: 9.12B (-3.6%)
|
8.08B
est: 8.29B (-2.5%)
|
9.00B
est: 9.28B (-3.0%)
|
9.79B
est: 10.00B (-2.0%)
|
10.85B
est: 11.06B (-1.9%)
|
11.83B
est: 12.09B (-2.1%)
|
13.11B
13.11B – 13.11B
+8.5% YoY
|
14.57B
14.57B – 14.57B
+11.1% YoY
|
16.35B
16.35B – 16.35B
+12.2% YoY
|
19.81B
19.81B – 19.81B
+21.1% YoY
|
| EPS |
154.01
est: 152.70 (+0.9%)
|
249.50
est: 223.85 (+11.5%)
|
234.46
est: 237.70 (-1.4%)
|
143.36
est: 184.60 (-22.3%)
|
157.05
est: 181.10 (-13.3%)
|
27.67
est: 190.00 (-85.4%)
|
195.45
est: 210.90 (-7.3%)
|
250.58
est: 246.50 (+1.7%)
|
214.78
est: 189.20 (+13.5%)
|
280.51
est: 287.00 (-2.3%)
|
292.41
est: 313.10 (-6.6%)
|
269.10
269.10 – 269.10
-14.1% YoY
|
289.30
289.30 – 289.30
+7.5% YoY
|
322.90
322.90 – 322.90
+11.6% YoY
|
587.10
587.10 – 587.10
+81.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Norio Tahara | President & Representative Director | — | male |
| Shinkatsu Morisawa | Chairman & Chief Executive Officer | — | male |
| Yoshimi Nishitani | Senior MD, GM of Sales Division, GM of SS Division & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6788.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
